IO Biotech, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: IO Biotech, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
IO Biotech, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 15.1 %, a 47.5% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	15.1	+4.85	+47.5%	Sep 30, 2024
Q2 2024	12	+2.95	+32.5%	Jun 30, 2024
Q1 2024	11.4	+3.81	+50.2%	Mar 31, 2024
Q4 2023	11.2	+5.04	+81.8%	Dec 31, 2023
Q3 2023	10.2	+5.01	+96.5%	Sep 30, 2023
Q2 2023	9.07	-3.67	-28.8%	Jun 30, 2023
Q1 2023	7.6			Mar 31, 2023
Q4 2022	6.16			Dec 31, 2022
Q3 2022	5.19			Sep 30, 2022
Q2 2022	12.7			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.